Yeongjoon Gil, Ph.D.Founder & CEO

INNOVATION for HUMAN

We are working to disrupt the healthcare industry through wearable technology .

CICLO by HUiNNO is a smart-watch that can instantaneously detect blood pressure, heart rate, ECG, and more for the health-conscious early adaptors and

people with blood pressure problems.

WHAT IS ONE OF THE MOST IMPORTANT VITAL SIGN?

BLOOD PRESSURE

Hypertension (High BP) is a leading cause of stroke, heart attack, dementia, kidney failure, etc.

PROBLEM

406,351deaths

(2007)

1in every

1.3minute

If you can continuously be aware of Blood Pressure to manage and

control hypertension, you can significantly reduce risk of

life-threatening complications

[1] Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes, “American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death”, Circulation 2008, pp. 1497-1518, 2009.

PROBLEM

Existing monitors cannot measure blood pressure continuously and conveniently

This is a big problem for hypertension patients

BP Monitors are very difficult and inconvenient to use

PROBLEM

All current devices are

• PRESSURE & CUFF BASED• VERY SLOW• CAN’T USE CONTINUOUSLY• UNCOMFORTABLE • INACCURATE

Wearable devices can’t measure Blood Pressure

PROBLEM

All of the wearable devices are focusing more on healthcare, but no device can measure the most vital sign:

BLOOD PRESSURE

Wearables Are Totally Failing

Wired News

As of September 30, there were 266 wearable devices on the market [1]

[1] http://www.wired.com/2014/11/where-fitness-trackers-fail/

Wearables Are Totally Failing

Wired News

Wearable medical devices are currently a $2.8b market and will grow 25% p.a. by 2019 to $8.3b[1].

[1] http://www.wired.com/2014/11/where-fitness-trackers-fail/

$2.8 B2014

$8.3 B2019

SOLUTION

CICLO by HUiNNO

INSTANT BLOOD PRESSURE

HIGHLY ACCURATE

CONVENIENT

1-seconds to measure BP

Provide up to 94% accuracy viacombining biometrics (ECG + PTT + SpO2 )

No cuffs or pressures to measure continuous and accurate BP

CICLO by HUiNNO

No-Delay Blood Pressure Measurement Algorithm(Patent in KR: 10-2014-0068122)

1 Secondto measure your BP every time

50 subject clinic trial at Pusan National University hospital

Provide BP measurement up to

94% Accuracyvia combining biometrics ( ECG + PTT + SpO2 )

95%+ accuracy receives

Grade Afrom BHS (British Hypertension Society)

42%

70%

86%

68%

84%

94%

≤5mmHg ≤10mmHg ≤15mmHg

PTT PTT(t), SpO2(t), ECG(t)

Blood Pressure Calculation Algorithm(Patent in KR: 10-2013-0116158)

Highly accurate ( 94% )

Convenient (Cuff-less)

Wearable Style UX(Patent in KR: 10-2013-0116165)

HUiNNO vs Other BP Monitors

1) ECG - Electrocardiogram

2) SpO2 - Saturation of peripheral Oxygen

Developer Parameter Accurate Instant ContinuousBiofeedback

Platform

Visi Mobile Oscillation

Withings Oscillation

Bpro PPG

Samsung Electronics

PTT

MIT Prototype

PTT

OUR DEVICE

ECG1) + PTT + SpO22)

MARKET

$1.2 Billionin 2015

55 MillionUsers in 2015

1 out of 3suffer from hypertension

Blood Pressure monitoring market is projected to growto 1.2 Billion USD in 2015

(HIS Media Group 2013)

Smart Watch users to grow to 55 Million in 2015(Business Insider 2014)

32.5% of adults in the U.S. over 20 suffer from hypertension (M brain trend monitor 2014.02)

Blood Pressure Monitor + Smart Watch Market

MARKET

Increase in demand for blood pressure measurement in smart devices

DEVICE APP / SERVICE CLOUD PLATFORM

16580

CUSTOMERS HEALTHCARE

Business Model

Business Development

Samsung

Hyundai

LG

LINA

OSCARIn NYC

PNUH

NDA by Samsung Electronics(Open Innovation Center in Palo-alto)

Strategy investor partnership Review(Hyundai Motors Venture Investment Team)

KT

Licensing Review(Future Convergence IT with Biometrics)

Proposed a New Product(For hypertension patients)

Pilot Project with Korea gov.(Tele-medicine or Tele-monitoring)

Partnership Review(Alternative for Misfit)

Strategically Partnership Review(About 500ea Ordering Review)

June.2014Incorporation in US

Dec.2014Working Mock-up

July.2014Incorporation in KR

Q1.2015Clinic trial

Q2.2015FDA approved

Q4.2015Launching

Q3.2015

Mass product

Milestone

HUiNNO. Inc.www.huinno.com

E-mail: kyzoon@huinno.com

INNOVATION for HUMAN